A review of quetiapine in combination with antidepressant therapy in patients with depression

References

• AdityanjeeSchulzSC2002Clinical use of quetiapine in disease states other than schizophreniaJ Clin Psychiatry6332812562145
   PubMed Web of Science ®Google Scholar
• AdsonDEKushnerMGEibenMK2004Preliminary experience with adjunctive quetiapine in patients receiving selective serotonin reuptake inhibitorsDepress Anxiety19121615022147
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association2000Diagnostic and statistical manual of mental disorders – text revisionWashington, DC
   Google Scholar
• ArvanitisLAMillerBGBorisonRL1997Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placeboBiol Psychiatry42233469270900
   PubMed Web of Science ®Google Scholar
• BauneBTCaliskanSTodderD2007Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depressionHum Psychopharmacol221917191266
   PubMed Web of Science ®Google Scholar
• BrecherMZukinSLeongRLong-term weight change with quetiapine treatment in schizophrenia: a comprehensive data review [poster]American College of Neuropsychopharmacology 43rd Annual MeetingSan Juan2004
   Google Scholar
• CalabreseJRKeckPEMacfaddenW2005A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depressionAm J Psychiatry16213516015994719
   PubMed Web of Science ®Google Scholar
• CheerSMWagstaffAJ2004Quetiapine – A review of its use in the management of schizophreniaCNS Drugs181739914871161
   PubMed Web of Science ®Google Scholar
• CoryaSAWilliamsonDSangerTM2006A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depressionDepress Anxiety233647216710853
   PubMed Web of Science ®Google Scholar
• DandoTMKeatingGM2005Quetiapine – A review of its use in acute mania and depression associated with bipolar disorderDrugs6525335116296876
   PubMed Web of Science ®Google Scholar
• Depression Guideline Panel1993Clinical practice guideline. depression in primary care: volume 2: treatment of major depression Publication no. 93–0551U.S. Department of Health and Human Services – Agency for Health Care Policy and Research
   Google Scholar
• DeVaneCLNemeroffCB2001Clinical pharmacokinetics of quetiapine – An atypical antipsychoticClin Pharmacokinet405092211510628
   PubMed Web of Science ®Google Scholar
• DevarajanSAliJDursunSM2006Quetiapine plus SSRI in treatment-resistant depression: possible mechanismsPsychopharmacology185402316538471
   PubMed Web of Science ®Google Scholar
• DoreeJPDesRJLewV2007Quetiapine augmentation of treatment-resistant depression: a comparison with lithiumCurr Med Res Opin233334117288688
   PubMed Web of Science ®Google Scholar
• DubeSAndersenSWPaulS2002Metanalysis of olanzapine-fluoxetine use in treatment-resistant depressionEur Neuropsychopharmacol12S180
   Web of Science ®Google Scholar
• DunnerDAmsterdamJSheltonR2003Adjunctive ziprasidone in treatment-resistant depression: A pilot study (Abstract NR238)The 156th APA Annual MeetingSan Francisco, CA
   Google Scholar
• GalynkerIKhanAGrebchenkoY2005Low-dose risperidone and quetiapine as monotherapy for comorbid anxiety and depressionJ Clin Psychiatry6654415816805
   PubMed Web of Science ®Google Scholar
• GentileS2006Long-term treatment with atypical antipsychotics and the risk of weight gain – A literature analysisDrug Saf293031916569080
   PubMed Web of Science ®Google Scholar
• GoldsteinJ1996Preclinical profile of seroquel (quetiapine): an atypical antipsychotic with clozapine-like pharmacology Schizophrenia: breaking down the barriersNew York, NYWiley and Sons
   Google Scholar
• GoodwinGMConsensus Group of the British Association of Psychopharmacology2003Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for PsychopharmacologyJ Psychopharmacol171497312870562
   PubMed Web of Science ®Google Scholar
• GredenJF2001The burden of disease for treatment-resistant depressionJ Clin Psychiatry62S2631
   PubMed Web of Science ®Google Scholar
• GreenbergPEKesslerRCBirnbaumHG2003The economic burden of depression in the United States: how did it change between 1990 and 2000?J Clin Psychiatry6414657514728109
   PubMed Web of Science ®Google Scholar
• GrimmSWStamsKRBuiK1997In vitro prediction of potential metabolic drug interactions for SeroquelSchizophr Res24198
   Web of Science ®Google Scholar
• GrunzeH2005Reevaluating therapies for bipolar depressionJ Clin Psychiatry66172516038598
   PubMed Web of Science ®Google Scholar
• HarrowMYonanCASandsJR1994Depression in Schizophrenia – Are Neuroleptics, Akinesia, or Anhedonia InvolvedSchizophr Bull20327388085135
   PubMed Web of Science ®Google Scholar
• HiroseSAshbyCR2002An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapyJ Clin Psychiatry63733612197455
   PubMed Web of Science ®Google Scholar
• HirschSRJolleyAG1989The dysphoric syndrome in schizophrenia and its implications for relapseBr J Psychiatry1554650
   Web of Science ®Google Scholar
• HirschfeldRSuppesTVietaE2006Quetiapine monotherapy for bipolar II depression: pooled results from two placebo-controlled studiesInternational Journal of Neuropsychopharmacology9S237
   Web of Science ®Google Scholar
• HirschfeldRMABowdenCLGitlinMJ2002Practice Guidelines for the treatment of the patients with Bipolar Disorder (revision)Am J Psychiatry159Suppl 4150
   Web of Science ®Google Scholar
• HussainMZWaheedWHussainS2005A comparison of unipolar depression treatment using antidepressants alone versus using antide-pressants in combination with quetiapineEur Neuropsychopharmacol15S453
   Web of Science ®Google Scholar
• InselTR2006Beyond efficacy: The STAR*D trialAm J Psychiatry1635716390879
   PubMed Web of Science ®Google Scholar
• JaberMRobinsonSWMissaleC1996Dopamine receptors and brain functionNeuropharmacology351503199025098
   PubMed Web of Science ®Google Scholar
• JohnsonDAW1988The significance of depression in the prediction of relapse in chronic-schizophreniaBr J Psychiatry15232033167364
   PubMed Web of Science ®Google Scholar
• KapurSLangloisXVinkenP2002The differential effects of atypical Antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: A pharmacological analysis in ratsJ Pharmacol Exp Ther30211293412183672
   PubMed Web of Science ®Google Scholar
• KasperS2004Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophreniaDepress Anxiety2044715368596
   PubMed Web of Science ®Google Scholar
• KasperSMuller-SpahnF2000Review of quetiapine and its clinical applications in schizophreniaExpert Opin Pharmacother178380111249516
   PubMedGoogle Scholar
• KeatingGMRobinsonDM2007Quetiapine: a review of its use in the treatment of bipolar depressionDrugs6710779517488148
   PubMed Web of Science ®Google Scholar
• KeckPEJrStrakowskiSMMcElroySL2000The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophreniaJ Clin Psychiatry61 Suppl 34910724127
   PubMed Web of Science ®Google Scholar
• KellerMB2005Issues in treatment-resistant depressionJ Clin Psychiatry6651216336031
   PubMed Web of Science ®Google Scholar
• KennedySHLamRWCohenNL2001Clinical guidelines for the treatment of depressive disorders IV. Medications and other biological treatmentsCan J Psychiatry4638S58S11441771
   PubMed Web of Science ®Google Scholar
• KhullarAChokkaPFullertonD2006Quetiapine as treatment of non-psychotic unipolar depression with residual symptoms: a double blind, randomized, placebo-controlled studyAmerican Psychiatric Association annual meetingToronto, Canada
   Google Scholar
• KonstantinidisAHrubosWNirnbergerG2007Quetiapine in combination with citalopram in patients with unipolar psychotic depressionProg Neuropsychopharmacol Biol Psychiatry31242716962224
   PubMed Web of Science ®Google Scholar
• LiebermanJAPerkinsDO2002Quetiapine: A 5-year update – IntroductionJ Clin Psychiatry6334
   Web of Science ®Google Scholar
• MartinRLCloningerCRGuzeSB1985Frequency and differential-diagnosis of depressive syndromes in schizophreniaJ Clin Psychiatry469132865255
   PubMed Web of Science ®Google Scholar
• MattinglyGIlivickyHCanaleJ2006Quetiapine augmentation for treatment-resistant depression [poster]The 159th Annual Meeting of the American Psychiatric AssociationToronto, Canada
   Google Scholar
• McIntyreAWGendronAMcIntyreA2006Quetiapine augmentation of SSRIs/SNRIs in major depression with anxiety [poster]The 159th Annual Meeting of the American Psychiatric AssociationToronto, Canada
   Google Scholar
• McIntyreRSTrakasKLinD2003Risk of weight gain associated with antipsychotic treatment: results from the Canadian National Outcomes Measurement Study in SchizophreniaCan J Psychiatry486899414674052
   PubMed Web of Science ®Google Scholar
• MeltzerHYCaseyDEGarverDL1998Atypical antipsychotics for treatment of depression in schizophrenia and affective disordersJ Clin Psychiatry59415
   Web of Science ®Google Scholar
• MilevRAbrahamGZaheerJ2006Add-on quetiapine for bipolar depression: a 12-month open-label trialCan J Psychiatry515233016933589
   PubMed Web of Science ®Google Scholar
• Muller-SiechenederFMullerMJHillertA1998Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndromeJ Clin Psychopharmacol18111209555596
   PubMed Web of Science ®Google Scholar
• MurrayCJLopezAD1996The global burden of diseaseBoston, MassachusettsHarvard School of Public Health, World Health Organization, World Bank
   Google Scholar
• NagyJ2005Efficacy, safety and tolerability of quetiapine: short-term high doses with long-term follow-upInt J Psychiatry Clin Pract91621
   PubMed Web of Science ®Google Scholar
• NemeroffCB2005Use of atypical antipsychotics in refractory depression and anxietyJ Clin Psychiatry66132116336032
   PubMed Web of Science ®Google Scholar
• NemeroffCBGharabawiGMCanusoCM2004Augmentation with risperidone in chronic resistant depression: A double-blind placebo-controlled maintenance trialNeuropsychopharmacology29S159
   Web of Science ®Google Scholar
• NemeroffCBKinkeadBGoldsteinJ2002Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosingJ Clin Psychiatry6351112562141
   PubMed Web of Science ®Google Scholar
• O’ConnorMSilverH1998Adding risperidone to selective serotonin reuptake inhibitor improves chronic depressionJ Clin Psychopharmacol1889919472852
   PubMed Web of Science ®Google Scholar
• OstroffRBNelsonJC1999Risperidone augmentation of selective serotonin reuptake inhibitors in major depressionJ Clin Psychiatry60256910221288
   PubMed Web of Science ®Google Scholar
• PapakostasGIPetersenTJKinrysG2005Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorderJ Clin Psychiatry6613263016259548
   PubMed Web of Science ®Google Scholar
• PapakostasGIPetersenTJNierenbergAA2004Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorderJ Clin Psychiatry652172115003076
   PubMed Web of Science ®Google Scholar
• PapakostasGISheltonRCSmithJ2007Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysisJ Clin Psychiatry688263117592905
   PubMed Web of Science ®Google Scholar
• PathakSJohnsESKowatchRA2005Adjunctive quetiapine for treatment-resistant adolescent major depressive disorder: A case seriesJ Child Adolesc Psychopharmacol1569670216190801
   PubMed Web of Science ®Google Scholar
• PitchotWAnsseauM2001Addition of olanzapine for treatment-resistant depressionAm J Psychiatry1581737811579017
   PubMed Web of Science ®Google Scholar
• RubinowDR2006Treatment strategies after SSRI failure – good news and bad newsN Engl J Med3541305716554533
   PubMed Web of Science ®Google Scholar
• RushAJTrivediMCarmodyTJ2004One-year clinical outcomes of depressed public sector outpatients: A benchmark for subsequent studiesBiol Psychiatry56465315219472
   PubMed Web of Science ®Google Scholar
• RushAJTrivediMHWisniewskiSR2006A Comparison of bupropion-SR, sertraline, and venlafaxine-XR following SSRI failure for depressed outpatients: a STAR*D reportN Engl J Med35412314216554525
   PubMed Web of Science ®Google Scholar
• SagudMMihaljevic-PelesAMuck-SelerD2006Quetiapine augmentation in treatment-resistant depression: a naturalistic studyPsychopharmacology1875111416802162
   PubMed Web of Science ®Google Scholar
• SajatovicMBrescanDWPerezDE2001Quetiapine alone and added to a mood stabilizer for serious mood disordersJ Clin Psychiatry627283211681770
   PubMed Web of Science ®Google Scholar
• SajatovicMMullenJASweitzerDE2002Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosisJ Clin Psychiatry6311566312523876
   PubMed Web of Science ®Google Scholar
• SchatzbergANemeroffCB2006Essentials of Clinical PsychopharmacologyArlington, VAAmerican Psychiatric Publishing Inc
   Google Scholar
• SeemanPTallericoT1998Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptorsMol Psychiatry3123349577836
   PubMed Web of Science ®Google Scholar
• SheltonRCTollefsonGDTohenM2001A novel augmentation strategy for treating resistant major depressionAm J Psychiatry158131411136647
   PubMed Web of Science ®Google Scholar
• SheltonRCWilliamsonDJCoryaSA2005Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistanceJ Clin Psychiatry6612899716259543
   PubMed Web of Science ®Google Scholar
• SimonJSNemeroffCB2005Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorderJ Clin Psychiatry6612162016259533
   PubMed Web of Science ®Google Scholar
• SoueryDAmsterdamJde MontignyC1999Treatment resistant depression: methodological overview and operational criteriaEur Neuropsychopharmacol9839110082232
   PubMed Web of Science ®Google Scholar
• SpragueDALoewenPSRaymondCB2004Selection of atypical anti-psychotics for the management of schizophreniaAnn Pharmacother383131914742771
   PubMed Web of Science ®Google Scholar
• TaraziFIZhangKBaldessariniRJ2001Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: Implications for antipsychotic drug treatmentJ Pharmacol Exp Ther2977111711303062
   PubMed Web of Science ®Google Scholar
• TaraziFIZhangKHBaldessariniRJ2002Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regionsPsychopharmacology1612637012021829
   PubMed Web of Science ®Google Scholar
• TargumSHassmanHBastaniB2005Use of quetiapine in treating nonpsychotic anxiety and depressive disorderSchizophr Bull315045
   Web of Science ®Google Scholar
• ThaseMECoryaSAOsuntokunO2007A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorderJ Clin Psychiatry682243617335320
   PubMed Web of Science ®Google Scholar
• ThaseMERushAJ1995Treatment resistant depressionPsychopharmacology: the fourth generation of progressNew York, NYRaven Press
   Google Scholar
• ThaseMEMacfaddenWWeislerRH2006Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)J Clin Psychopharmacol26600917110817
   PubMed Web of Science ®Google Scholar
• TohenMVietaECalabreseJ2003Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depressionArch Gen Psychiatry6010798814609883
   PubMed Web of Science ®Google Scholar
• TollefsonGDSangerTMLuYL1998Depressive signs and symptoms in schizophrenia – A prospective blinded trial of olanzapine and haloperidolArch Gen Psychiatry5525089510219
   PubMed Web of Science ®Google Scholar
• VavrusovaL2002Quetiapine in the treatment of non-psychotic depression (P.2 E 037)Int J Neuropsychopharmacol5Suppl 1
   Google Scholar
• VietaEReinaresMCorbellaB2001Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorderJ Clin Psychopharmacol214697311593070
   PubMed Web of Science ®Google Scholar
• VinerMWChenYXBakshiI2003Low-dose risperidone augmentation of antidepressants in nonpsychotic depressive disorders with suicidal ideationJ Clin Psychopharmacol23104612544386
   PubMed Web of Science ®Google Scholar
• World Health OrganizationWorld Health Report 2001 Mental Health: New UnderstandingNew Hope Geneva, SwitzerlandWorld Health Organization2001
   Google Scholar
• YargicLICorapciogluAKocabasogluN2004A prospective randomized single-blind, multicenter trial comparing the efficacy and safety of paroxetine with and without quetiapine therapy in depression associated with anxietyInt J Psychiatry Clin Pract820511
   PubMed Web of Science ®Google Scholar
• YathamLNGoldsteinJMVietaE2005Atypical antipsychotics in bipolar depression: Potential mechanisms of actionJ Clin Psychiatry6640816038601
   PubMed Web of Science ®Google Scholar
• ZarateCARothschildAFletcherKE2000Clinical predictors of acute response with quetiapine in psychotic mood disordersJ Clin Psychiatry61185910817103
   PubMed Web of Science ®Google Scholar